TY - JOUR
T1 - GRADE Equity Guidelines 3
T2 - Health equity considerations in rating the certainty of synthesized evidence
AU - Welch, Vivian A
AU - Akl, Elie A
AU - Pottie, Kevin
AU - Ansari, Mohammed T
AU - Briel, Matthias
AU - Christensen, Robin
AU - Dans, Antonio
AU - Dans, Leonila
AU - Eslava-Schmalbach, Javier H
AU - Guyatt, Gordon
AU - Hultcrantz, Monica
AU - Jull, Janet
AU - Katikireddi, Srinivasa Vittal
AU - Lang, Eddy
AU - Matovinovic, Elizabeth
AU - Meerpohl, Joerg
AU - Morton, Rachael
AU - Mosdøl, Annhild
AU - Murad, M Hassan
AU - Petkovic, Jennifer
AU - Schunemann, Holger J
AU - Sharaf, Ravi
AU - Shea, Beverley
AU - Singh, Jasvinder A
AU - Solà, Ivan
AU - Stanev, Roger
AU - Stein, Airton Tetelbom
AU - Thabane, Lehana
AU - Tonia, Thomy
AU - Tristan, Mario
AU - Vitols, Sigurd
AU - Watine, Joseph
AU - Tugwell, Peter
N1 - Copyright © 2017. Published by Elsevier Inc.
PY - 2017/4/4
Y1 - 2017/4/4
N2 - OBJECTIVE: The aim of this paper is to describe a conceptual framework for how to consider health equity in the GRADE (Grading Recommendations Assessment and Development Evidence) guideline development process.STUDY DESIGN AND SETTING: Consensus-based guidance developed by the GRADE working group members and other methodologists.RESULTS: We developed consensus-based guidance to help address health equity when rating the certainty of synthesized evidence (i.e., quality of evidence). When health inequity is determined to be a concern by stakeholders, we propose five methods for explicitly assessing health equity: 1) Include health equity as an outcome; 2) Consider patient-important outcomes relevant to health equity; 3) Assess differences in the relative effect size of the treatment; 4) Assess differences in baseline risk and the differing impacts on absolute effects; and 5) Assess indirectness of evidence to disadvantaged populations and/or settings.CONCLUSION: The most important priority for research on health inequity and guidelines is to identify and document examples where health equity has been considered explicitly in guidelines. Although there is a weak scientific evidence base for assessing health equity, this should not discourage the explicit consideration of how guidelines and recommendations affect the most vulnerable members of society.
AB - OBJECTIVE: The aim of this paper is to describe a conceptual framework for how to consider health equity in the GRADE (Grading Recommendations Assessment and Development Evidence) guideline development process.STUDY DESIGN AND SETTING: Consensus-based guidance developed by the GRADE working group members and other methodologists.RESULTS: We developed consensus-based guidance to help address health equity when rating the certainty of synthesized evidence (i.e., quality of evidence). When health inequity is determined to be a concern by stakeholders, we propose five methods for explicitly assessing health equity: 1) Include health equity as an outcome; 2) Consider patient-important outcomes relevant to health equity; 3) Assess differences in the relative effect size of the treatment; 4) Assess differences in baseline risk and the differing impacts on absolute effects; and 5) Assess indirectness of evidence to disadvantaged populations and/or settings.CONCLUSION: The most important priority for research on health inequity and guidelines is to identify and document examples where health equity has been considered explicitly in guidelines. Although there is a weak scientific evidence base for assessing health equity, this should not discourage the explicit consideration of how guidelines and recommendations affect the most vulnerable members of society.
KW - Journal Article
U2 - 10.1016/j.jclinepi.2017.01.015
DO - 10.1016/j.jclinepi.2017.01.015
M3 - Journal article
C2 - 28389397
SN - 0895-4356
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
ER -